Trigger values for investigation of hormonal activity in drinking water and its sources using CALUX bioassays
Publication date
2013
Authors
Brand, W.
Jongh, C.M. de
Linden, S.C.
Mennes, W.
Puijker, L.M.
Leeuwen, C.J. van
Wezel, A.P. van
Schriks, M.
Heringa, M.B.
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
(c) UU Universiteit Utrecht, 2013
Abstract
To screen for hormonal activity in water samples, highly sensitive in vitro CALUX bioassays are available
which allow detection of estrogenic (ERα), androgenic (AR), progestagenic (PR), and glucocorticoid (GR) activities.
This paper presents trigger values for the ERα, AR, PR, and GR CALUX bioassays for agonistic hormonal
activities in (drinking) water, which define a level above which human health risk cannot be waived a
priori and additional examination of specific endocrine activity may be warranted. The trigger values are
based on 1) acceptable or tolerable daily intake (ADI/TDI) values of specific compounds, 2) pharmacokinetic
factors defining their bioavailability, 3) estimations of the bioavailability of unknown compounds with equivalent
hormonal activity, 4) relative endocrine potencies, and 5) physiological, and drinking water allocation
factors. As a result, trigger values of 3.8 ng 17β-estradiol (E2)-equivalents (eq)/L, 11 ng dihydrotestosterone
(DHT)-eq/L, 21 ng dexamethasone (DEX)-eq/L, and 333 ng Org2058-eq/L were derived. Benchmark Quotient
(BQ) values were derived by dividing hormonal activity in water samples by the derived trigger using the
highest concentrations detected in a recent, limited screening of Dutch water samples, and were in the
order of (value) AR (0.41) > ERα (0.13) > GR (0.06) > PR (0.04). The application of trigger values derived
in the present study can help to judge measured agonistic hormonal activities in water samples using the
CALUX bioassays and help to decide whether further examination of specific endocrine activity followed by
a subsequent safety evaluation may be warranted, or whether concentrations of such activity are of low priority
with respect to health concerns in the human population. For instance, at one specific drinking water
production site ERα and AR (but no GR and PR) activities were detected in drinking water, however, these
levels are at least a factor 83 smaller than the respective trigger values, and therefore no human health
risks are to be expected from hormonal activity in Dutch drinking water from this site.
Keywords
Estrogens, Endocrine disrupting compounds, Androgens, Glucocorticoids, Progestogens, In vitro bioassays